Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I trial of combination of ublituximab + TGR-1202 + bendamustine in patients with advanced Diffuse Large B-Cell Lymphoma (DLBCL) and follicular lymphoma

Trial Profile

A phase I trial of combination of ublituximab + TGR-1202 + bendamustine in patients with advanced Diffuse Large B-Cell Lymphoma (DLBCL) and follicular lymphoma

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bendamustine (Primary) ; Ublituximab (Primary) ; Umbralisib (Primary)
  • Indications Diffuse large B cell lymphoma; Follicular lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 04 Dec 2018 Results (n=39) presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
    • 26 Jun 2017 Results published in a TG Therapeutics media release.
    • 26 Jun 2017 According to a TG Therapeutics media release, data from this trial was presented at the 22nd European Hematology Association (EHA) Annual Congress.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top